<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30713326</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1349-7235</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>58</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Internal medicine (Tokyo, Japan)</Title>
          <ISOAbbreviation>Intern Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Recent Updates on the Relationship between Cancer and Autoimmune Pancreatitis.</ArticleTitle>
        <Pagination>
          <StartPage>1533</StartPage>
          <EndPage>1539</EndPage>
          <MedlinePgn>1533-1539</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2169/internalmedicine.2210-18</ELocationID>
        <Abstract>
          <AbstractText>Autoimmune pancreatitis (AIP) is now considered a pancreatic manifestation of a newly proposed disease condition, IgG4-related disease (IgG4-RD). IgG4-RD is characterized by enhanced IgG4 antibody responses and multiple organ involvements. Recent epidemiological studies have addressed the incidence of cancer in patients with AIP and/or IgG4-RD. Surprisingly, a significant number of AIP patients were detected with cancer at or within one year of the diagnosis of AIP. Furthermore, around 50% of all cancers detected in AIP patients comprised mainly 3 types (gastric, lung, and prostate cancer). Thus, AIP appears to be associated with cancer of other organs rather than the pancreas itself, which suggests that AIP is not a pre-cancerous condition of the pancreas. Moreover, the simultaneous occurrence of cancer and AIP in many patients has led to the establishment of an attractive concept that AIP might sometimes arise from co-existing cancers as a paraneoplastic syndrome.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Okamoto</LastName>
            <ForeName>Ayana</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Watanabe</LastName>
            <ForeName>Tomohiro</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kamata</LastName>
            <ForeName>Ken</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Minaga</LastName>
            <ForeName>Kosuke</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kudo</LastName>
            <ForeName>Masatoshi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>02</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Intern Med</MedlineTA>
        <NlmUniqueID>9204241</NlmUniqueID>
        <ISSNLinking>0918-2918</ISSNLinking>
      </MedlineJournalInfo>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000077733" MajorTopicYN="N">Immunoglobulin G4-Related Disease</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010195" MajorTopicYN="N">Pancreatitis</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010257" MajorTopicYN="N">Paraneoplastic Syndromes</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">IgG4-related disease</Keyword>
        <Keyword MajorTopicYN="N">autoimmune pancreatitis</Keyword>
        <Keyword MajorTopicYN="N">cancer</Keyword>
      </KeywordList>
      <CoiStatement>
        <b>The authors state that they have no Conflict of Interest (COI).</b>
      </CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30713326</ArticleId>
        <ArticleId IdType="pmc">PMC6599917</ArticleId>
        <ArticleId IdType="doi">10.2169/internalmedicine.2210-18</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Finkelberg DL, Sahani D, Deshpande V, Brugge WR. 
Autoimmune pancreatitis. N Engl J Med
355: 2670-2676, 2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17182992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamisawa T, Chari ST, Lerch MM, Kim MH, Gress TM, Shimosegawa T. 
Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut
62: 1373-1380, 2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23749606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamisawa T, Okamoto A. 
Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol
41: 613-625, 2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2780632</ArticleId>
            <ArticleId IdType="pubmed">16932997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stone JH, Zen Y, Deshpande V. 
IgG4-related disease. N Engl J Med
366: 539-551, 2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22316447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hart PA, Zen Y, Chari ST. 
Recent advances in autoimmune pancreatitis. Gastroenterology
149: 39-51, 2015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25770706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mitsuyama T, Uchida K, Sumimoto K, et al. . 
Comparison of neutrophil infiltration between type 1 and type 2 autoimmune pancreatitis. Pancreatology
15: 271-280, 2015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25818196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiba T, Marusawa H, Ushijima T. 
Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology
143: 550-563, 2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22796521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bansal P, Sonnenberg A. 
Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology
109: 247-251, 1995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7797022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malka D, Hammel P, Maire F, et al. . 
Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut
51: 849-852, 2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1773474</ArticleId>
            <ArticleId IdType="pubmed">12427788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiokawa M, Kodama Y, Yoshimura K, et al. . 
Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol
108: 610-617, 2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23318486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirano K, Tada M, Sasahira N, et al. . 
Incidence of malignancies in patients with IgG4-related disease. Intern Med
53: 171-176, 2014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24492683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hart PA, Law RJ, Dierkhising RA, Smyrk TC, Takahashi N, Chari ST. 
Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas
43: 417-421, 2014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24622072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamamoto M, Takahashi H, Tabeya T, et al. . 
Risk of malignancies in IgG4-related disease. Mod Rheumatol
22: 414-418, 2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21894525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asano J, Watanabe T, Oguchi T, et al. . 
Association between immunoglobulin G4-related disease and malignancy within 12 years after diagnosis: an analysis after longterm followup. J Rheumatol
42: 2135-2142, 2015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26472416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schneider A, Hirth M, Munch M, et al. . 
Risk of cancer in patients with autoimmune pancreatitis: a single-center experience from germany. Digestion
95: 172-180, 2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28226313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallace ZS, Wallace CJ, Lu N, Choi HK, Stone JH. 
Association of IgG4-related disease with history of malignancy. Arthritis Rheumatol
68: 2283-2289, 2016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7524567</ArticleId>
            <ArticleId IdType="pubmed">27273903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirano K, Isayama H, Tada M, Koike K. 
Association between autoimmune pancreatitis and malignancy. Clin J Gastroenterol
7: 200-204, 2014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26183737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukui T, Mitsuyama T, Takaoka M, Uchida K, Matsushita M, Okazaki K. 
Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med
47: 151-155, 2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18239323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loos M, Esposito I, Hedderich DM, et al. . 
Autoimmune pancreatitis complicated by carcinoma of the pancreatobiliary system: a case report and review of the literature. Pancreas
40: 151-154, 2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21160372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ikeura T, Miyoshi H, Uchida K, et al. . 
Relationship between autoimmune pancreatitis and pancreatic cancer: a single-center experience. Pancreatology
14: 373-379, 2014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25278307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watanabe T, Kudo M, Strober W. 
Immunopathogenesis of pancreatitis. Mucosal Immunol
10: 283-298, 2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27848953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamisawa T, Horiguchi S, Hayashi Y, et al. . 
K-ras mutation in the major duodenal papilla and gastric and colonic mucosa in patients with autoimmune pancreatitis. J Gastroenterol
45: 771-778, 2010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20157749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khalid A, Dewitt J, Ohori NP, et al. . 
EUS-FNA mutational analysis in differentiating autoimmune pancreatitis and pancreatic cancer. Pancreatology
11: 482-486, 2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21997479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asano N, Imatani A, Watanabe T, et al. . 
Cdx2 expression and intestinal metaplasia induced by H. pylori infection of gastric cells is regulated by NOD1-mediated innate immune responses. Cancer Res
76: 1135-1145, 2016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4799656</ArticleId>
            <ArticleId IdType="pubmed">26759244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cornfield J, Haenszel W, Hammond EC, Lilienfeld AM, Shimkin MB, Wynder EL. 
Smoking and lung cancer: recent evidence and a discussion of some questions. Int J Epidemiol
38: 1175-1191, 2009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19773415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Merriel SWD, Funston G, Hamilton W. 
Prostate cancer in primary care. Adv Ther
35: 1285-1294, 2018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6133140</ArticleId>
            <ArticleId IdType="pubmed">30097885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah AA, Casciola-Rosen L, Rosen A. 
Review: cancer-induced autoimmunity in the rheumatic diseases. Arthritis Rheumatol
67: 317-326, 2015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4312216</ArticleId>
            <ArticleId IdType="pubmed">25371098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giat E, Ehrenfeld M, Shoenfeld Y. 
Cancer and autoimmune diseases. Autoimmun Rev
16: 1049-1057, 2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28778707</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
